Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
+1,320,571
Put/Call ratio
391%
SEC-reported price per share
$50.89
Number of holders
211
Value change
+$70,434,976
Number of buys
109
Open additional details 1 more signal available
Number of sells
112
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,919,423

Security key

604749101

Report period

Q2 2025

Institutions

211

Top holders

10

Ownership snapshot

Top reported holders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
James E. Flynn
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5 13F Highest disclosed value: $306,120,201 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Frazier Life Sciences Management, L.P. has the largest disclosed position value at $306.12M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value Top 5
James E. Flynn $90.96M
NEA Partners 16, L.P. $61.29M
New Enterprise Associates 16, L.P. $61.29M
Anthony A. Florence Jr. $328.9K
Mohamad Makhzoumi $318.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
James E. Flynn
3/4/5
* Possible Member of 10% Group, 10%+ Owner
—
denominator unverified
$90,958,032
3,244,434 shares
— 06 Jun 2022
NEA Partners 16, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$61,291,541
2,186,243 shares
— 13 Jun 2023
New Enterprise Associates 16, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$61,291,541
2,186,243 shares
— 13 Jun 2023
Anthony A. Florence Jr.
3/4/5
10%+ Owner
—
denominator unverified
$328,907
11,732 shares
— 13 Jun 2023
Mohamad Makhzoumi
3/4/5
10%+ Owner
—
denominator unverified
$318,142
11,348 shares
— 13 Jun 2023
Scott D. Sandell
3/4/5
10%+ Owner
—
denominator unverified
$318,142
11,348 shares
— 13 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
211
Shares
55,393,029
Rows available
211
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
213
Q2 2025 holders
211
Holder diff
-2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .